30.12.2012 Views

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

is evident form the fact [51] that the majority of the marketed drugs are highly<br />

soluble ( > 55% in classes I <strong>and</strong> III). Sometimes, enhancing the permeability by altering<br />

the drug ’ s chemical structure may be counterproductive. This because of the<br />

associated increase in molecular weight that attenuates the permeability enhancement<br />

gained with structural modifi cation. On the other h<strong>and</strong>, optimization of drug<br />

solubility may be more fruitful if the poor permeability is overcome by increasing<br />

drug solubility to provide a high drug concentration at the absorption site. However,<br />

this may be a diffi cult strategy if the dose is very high. The preformulation team<br />

should use the “ appropriate tools ” at every stage of the drug discovery <strong>and</strong> development<br />

process to guide or alert other development teams about drug solubility <strong>and</strong><br />

permeability issues (Figure 17 ).<br />

6.2.4<br />

Solubility/permeability<br />

Maximum absorbable dose<br />

BCS classification<br />

Ora ldosage form<br />

development<br />

FIGURE 17 Flow chart for determining absorption potential of a drug during drug discovery<br />

<strong>and</strong> development. Solubility <strong>and</strong> permeability studies from preclinical phase are used to<br />

calculate the maximum absorbable dose <strong>and</strong>, when correlated to BCS, this can provide information<br />

on its biopharmaceutics class. This is useful to estimate if the drug absorption would<br />

be dissolution <strong>and</strong>/or permeability limited for developing appropriate drug delivery<br />

strategies.<br />

STABILITY CHARACTERISTICS<br />

STABILITY CHARACTERISTICS 965<br />

Early drug discovery<br />

Exploratory studies<br />

Drug development<br />

Clinical development<br />

Drug stability is an essential component of preformulation testing. Establishing<br />

the stability of the drug under a variety of conditions is an expensive <strong>and</strong> time -<br />

consuming process. It cannot be overemphasized that the availability of a stability -<br />

indicating assay is the key to stability studies. The preformulation scientist works<br />

closely with the analytical method development team in developing a stability -<br />

indicating assay. During the early stages, a foolproof stability - indicating assay may

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!